CANDID THERAPEUTICS
HQ - San Diego, CA
Summary
Candid Therapeutics is focused on developing innovative T-cell engager antibodies to selectively deplete autoreactive B-cells, aiming to transform the treatment of autoimmune diseases with safer and more effective therapies.
Deals Overview
Total Dealss1
Valued Deals1
Total Value£ 282 M
Avg. Deal Size£ 282 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
